Stopping Mesalamine Therapy in Patients With Crohn’s Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes-Reference-Cited by-同舟云学术

Stopping Mesalamine Therapy in Patients With Crohn’s Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes

Published:2020-05 Issue:5 Volume:18 Page:1152-1160.e1
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Ungaro Ryan C.,Limketkai Berkeley N.,Jensen Camilla Bjørn,Yzet Clara,Allin Kristine H.,Agrawal Manasi,Ullman Thomas,Burisch Johan^ORCID,Jess Tine,Colombel Jean-Frederic

Funder

National Institutes of Health

National Center for Advancing Translational Science Clinical and Translational Science

Career Development

Crohn's and Colitis Foundation

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference21 articles.

1. Crohn’s disease;Torres;Lancet,2017

2. European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management;Gomollón;J Crohns Colitis,2017

3. ACG clinical guideline: management of crohn’s disease in adults;Lichtenstein;Am J Gastroenterol,2018

4. 5-Aminosalicylic acid (mesalazine) use in Crohn’s disease: a survey of the opinions and practice of Australian gastroenterologists;Gearry;Inflamm Bowel Dis,2007

5. Management of Crohn’s disease - are guidelines transferred to clinical practice?;Klag;United European Gastroenterol J,2015

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuing or stopping 5‐aminosalicylates in patients with inflammatory bowel disease on anti‐TNF therapy: A nationwide population‐based study;Alimentary Pharmacology & Therapeutics;2024-06-12

2. Discontinuation of therapy in inflammatory bowel disease: Current views;World Journal of Clinical Cases;2024-04-06

3. Natural History of Pediatric Patients With Crohn’s Disease Treated With Mesalamine Therapy;JPGN Reports;2023-11

4. Impact of Concomitant 5-Aminosalicylic Acid Therapy on Vedolizumab Efficacy and Safety in Inflammatory Bowel Disease: Post Hoc Analyses of Clinical Trial Data;Journal of Crohn's and Colitis;2023-07-26

5. Burden of Crohn’s Disease in the United States Medicaid Population, 2010–2019;Clinical Gastroenterology and Hepatology;2023-05